发明名称 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
摘要 The invention provides a method for increasing hydration and lubrication of lacrimal tissues in a subject in need of such treatment. The method comprises administering to the subject a nicotinic acetylcholine receptor agonist such as nicotine and its analogs, transmetanicotine and its analogs, epibatidine and it analogs, lobeline and its analogs, pyridol derivatives, para-alkylthiophenol derivatives, and imidacloprid and its analogs, in an amount effective to stimulate mucus secretion in the lacrimal system. Pharmaceutical formulations and methods of making the same are also disclosed. Methods of administering the formulation include: topical administration via a liquid, gel, cream, or as part of a contact lens or selective release membrane; or systemic administration via nasal drops or spray, inhalation by nebulizer or other device, oral form (liquid or pill), injectable, intra-operative instillation, suppository form, or transdermal form. The invention is useful for treating dry eye disease and corneal injury.
申请公布号 US6277855(B1) 申请公布日期 2001.08.21
申请号 US20000557059 申请日期 2000.04.21
申请人 INSPIRE PHARMACEUTICALS, INC. 发明人 YERXA BENJAMIN R.
分类号 C07D487/04;A61K9/02;A61K9/06;A61K9/08;A61K9/10;A61K9/12;A61K9/127;A61K9/14;A61K9/70;A61K31/40;A61K31/407;A61K31/42;A61K31/44;A61K31/4406;A61K31/444;A61K31/4545;A61K31/465;A61K31/4995;A61K31/505;A61K45/00;A61P27/02;A61P43/00;C07D213/38;C07D401/04;C07D401/06;C07D401/12;C07D413/04;C07D487/18;(IPC1-7):A61K31/505 主分类号 C07D487/04
代理机构 代理人
主权项
地址